tiprankstipranks
Advertisement

SFLO - ETF AI Analysis

Compare

Top Page

SFLO

VictoryShares Small Cap Free Cash Flow ETF (SFLO)

Rating:68Neutral
Price Target:
SFLO’s rating suggests it is a solid but not top-tier ETF, reflecting a mix of strong and more challenged small-cap holdings. Strong contributors like Scorpio Tankers, SM Energy, and Nutex Health support the fund with solid profitability, revenue growth, and generally positive outlooks, while weaker names such as Oscar Health and Crocs, which face profitability, cash flow, and growth challenges, likely weigh on the overall rating. The main risk factor is exposure to smaller companies that can be volatile, with several holdings showing valuation concerns, legal or operational issues, and bearish technical trends.
Positive Factors
Strong Recent Performance
The ETF has shown strong gains over the past month, three months, and year to date, indicating solid recent momentum.
Healthy Asset Size
With several hundred million dollars in assets, the fund is large enough to offer stability and trading liquidity for everyday investors.
Broad Sector Mix in Small Caps
Holdings spread across technology, health care, consumer sectors, energy, and industrials help reduce the impact of weakness in any single industry.
Negative Factors
Higher Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which means more of the returns go toward fees instead of to investors.
Heavy U.S. Concentration
Almost all of the ETF’s holdings are in U.S. companies, offering very limited geographic diversification.
Mixed Performance Among Top Holdings
While several top positions have delivered strong gains, a few key holdings have shown weak or negative performance, which can drag on overall returns.

SFLO vs. SPDR S&P 500 ETF (SPY)

SFLO Summary

SFLO is the VictoryShares Small Cap Free Cash Flow ETF, which follows the Victory US Small Cap Free Cash Flow Index. It invests mainly in smaller U.S. companies that generate solid excess cash from their businesses. The fund spreads money across many sectors like technology, health care, and consumer companies, with holdings such as Lyft and Crocs. Someone might consider SFLO if they want growth potential from smaller companies while still focusing on financially healthier businesses. However, small-cap stocks can be very volatile, so the value of this ETF can go up and down more sharply than the overall market.
How much will it cost me?The VictoryShares Small Cap Free Cash Flow ETF (SFLO) has an expense ratio of 0.49%, which means you’ll pay $4.90 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed, focusing on small-cap companies with strong free cash flow. Active management typically involves more research and oversight, which can increase costs.
What would affect this ETF?The VictoryShares Small Cap Free Cash Flow ETF (SFLO) could benefit from economic growth in the U.S., as its focus on small-cap companies with strong free cash flow positions these firms to thrive in expanding markets. Positive trends in technology and energy sectors, which make up a significant portion of the ETF, could further drive performance. However, rising interest rates or economic slowdowns may negatively impact small-cap companies, as they often face higher borrowing costs and are more sensitive to market fluctuations.

SFLO Top 10 Holdings

SFLO is leaning into U.S. small caps with a tech-and-health-care tilt, and a few standout names are doing the heavy lifting. SM Energy and Scorpio Tankers have been rising steadily, giving the fund a solid boost from the energy side. Oscar Health and Jazz Pharmaceuticals add some punch from health care, with both trending higher in recent months. On the flip side, Lyft and Symbotic are losing steam, acting as small speed bumps. Overall, the ETF is diversified but still driven by a handful of rising small-cap stories.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Oscar Health2.25%$12.47M$6.73B61.09%
49
Neutral
Jazz Pharmaceuticals1.51%$8.40M$14.77B118.83%
64
Neutral
Scorpio Tankers1.44%$8.00M$3.86B87.49%
75
Outperform
Lyft1.42%$7.85M$5.25B-7.41%
69
Neutral
SM Energy1.34%$7.43M$7.47B31.13%
72
Outperform
Symbotic1.31%$7.29M$29.42B61.93%
70
Outperform
Peloton Interactive1.22%$6.77M$2.62B-9.86%
45
Neutral
Tutor Perini1.20%$6.67M$3.86B93.84%
65
Neutral
Crocs1.16%$6.43M$5.89B16.34%
63
Neutral
Clinigence Holdings1.15%$6.36M$898.57M-23.03%
74
Outperform

SFLO Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
31.65
Positive
100DMA
30.82
Positive
200DMA
29.84
Positive
Market Momentum
MACD
0.37
Negative
RSI
66.13
Neutral
STOCH
89.43
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SFLO, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 32.70, equal to the 50-day MA of 31.65, and equal to the 200-day MA of 29.84, indicating a bullish trend. The MACD of 0.37 indicates Negative momentum. The RSI at 66.13 is Neutral, neither overbought nor oversold. The STOCH value of 89.43 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SFLO.

SFLO Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$576.11M0.49%
68
Neutral
$982.22M0.20%
65
Neutral
$887.68M0.48%
72
Outperform
$732.53M0.09%
64
Neutral
$688.79M0.38%
67
Neutral
$669.90M0.42%
68
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SFLO
VictoryShares Small Cap Free Cash Flow ETF
33.48
8.75
35.38%
GSSC
Goldman Sachs Activebeta U.S. Small Cap Equity ETF
OUSM
OShares U.S. Small-Cap Quality Dividend ETF
BBSC
JPMorgan BetaBuilders U.S. Small Cap Equity ETF
EES
WisdomTree U.S. SmallCap Fund
JHSC
John Hancock Multifactor Small Cap ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement